ReviewJournal of cancer research and clinical oncology2006
Optimizing the use of aromatase inhibitors in adjuvant therapy for postmenopausal patients with hormone-responsive early breast cancer: current and future prospects.
Walter Jonat et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.